Yayın:
Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)

dc.contributor.authorTurk, Erdinc
dc.contributor.authorTekeli, Ibrahim Ozan
dc.contributor.authorCorum, Orhan
dc.contributor.authorDurna Corum, Duygu
dc.contributor.authorKirgiz, Fatma Ceren
dc.contributor.authorCetin, Gul
dc.contributor.authorArslan Atessahin, Dilek
dc.contributor.authorUney, Kamil
dc.date.accessioned2026-01-04T15:16:31Z
dc.date.issued2021-04-12
dc.description.abstractAbstractThe aim of this study was to determine the pharmacokinetics of meloxicam (MLX), carprofen (CRP), and tolfenamic acid (TA) in Japanese quails (Coturnix coturnix japonica) following intramuscular (IM) and oral administration at doses of 1, 10, and 2 mg/kg, respectively. A total of 72 quails were randomly divided into 3 equal groups as MLX, CRP, and TA. Each group was separated into two sub‐groups that received IM and oral administration of each drug. Plasma concentrations of MLX, CRP, and TA were determined using HPLC‐UV and analyzed by non‐compartmental method. The t1/2ʎzand MRT of MLX, CRP, and TA after oral administration were similar to those after IM administration. The Vdarea/F of MLX, CRP, and TA after IM administration was 0.28, 2.05, and 0.20 L/kg. The Cl/F of MLX, CRP, and TA after IM administration was 0.12, 0.19, and 0.09 L/h/kg. MLX, CRP, and TA after oral administration showed significantly lower Cmaxand longer Tmaxcompared with IM administration. The relative bioavailability of MLX, CRP, and TA following oral administration in quails was 76.13%, 61.46%, and 57.32%, respectively. The IM and oral route of MLX, CRP, and TA can be used for the treatment of various conditions in quails. However, further research is necessary to determine the pharmacodynamics and safety of MLX, CRP, and TA before use in quails.
dc.description.urihttps://doi.org/10.1111/jvp.12972
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/33846990
dc.description.urihttps://dx.doi.org/10.1111/jvp.12972
dc.identifier.doi10.1111/jvp.12972
dc.identifier.eissn1365-2885
dc.identifier.endpage396
dc.identifier.issn0140-7783
dc.identifier.openairedoi_dedup___::c91540fc88affde2facebaddeab4db8d
dc.identifier.orcid0000-0003-1735-1774
dc.identifier.orcid0000-0002-6845-2279
dc.identifier.orcid0000-0003-3168-2510
dc.identifier.orcid0000-0003-1567-991x
dc.identifier.orcid0000-0002-8454-5336
dc.identifier.orcid0000-0001-9110-2069
dc.identifier.orcid0000-0002-1528-9367
dc.identifier.orcid0000-0002-8674-4873
dc.identifier.pubmed33846990
dc.identifier.scopus2-s2.0-85104109443
dc.identifier.startpage388
dc.identifier.urihttps://hdl.handle.net/20.500.12597/38712
dc.identifier.volume44
dc.identifier.wos000639360600001
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofJournal of Veterinary Pharmacology and Therapeutics
dc.rightsCLOSED
dc.subjectCarbazoles
dc.subjectAdministration, Oral
dc.subjectAnimals
dc.subjectortho-Aminobenzoates
dc.subjectCoturnix
dc.subjectMeloxicam
dc.subject.sdg3. Good health
dc.titlePharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (Coturnix coturnix japonica)
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Erdinc Turk","name":"Erdinc","surname":"Turk","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0003-1735-1774"},"provenance":null}},{"fullName":"Ibrahim Ozan Tekeli","name":"Ibrahim Ozan","surname":"Tekeli","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0002-6845-2279"},"provenance":null}},{"fullName":"Orhan Corum","name":"Orhan","surname":"Corum","rank":3,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3168-2510"},"provenance":null}},{"fullName":"Duygu Durna Corum","name":"Duygu","surname":"Durna Corum","rank":4,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0003-1567-991x"},"provenance":null}},{"fullName":"Fatma Ceren Kirgiz","name":"Fatma Ceren","surname":"Kirgiz","rank":5,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8454-5336"},"provenance":null}},{"fullName":"Gul Cetin","name":"Gul","surname":"Cetin","rank":6,"pid":{"id":{"scheme":"orcid_pending","value":"0000-0001-9110-2069"},"provenance":null}},{"fullName":"Dilek Arslan Atessahin","name":"Dilek","surname":"Arslan Atessahin","rank":7,"pid":{"id":{"scheme":"orcid","value":"0000-0002-1528-9367"},"provenance":null}},{"fullName":"Kamil Uney","name":"Kamil","surname":"Uney","rank":8,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8674-4873"},"provenance":null}}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"0301 basic medicine"},"provenance":null},{"subject":{"scheme":"FOS","value":"0403 veterinary science"},"provenance":null},{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Carbazoles"},"provenance":null},{"subject":{"scheme":"keyword","value":"Administration, Oral"},"provenance":null},{"subject":{"scheme":"keyword","value":"Animals"},"provenance":null},{"subject":{"scheme":"keyword","value":"ortho-Aminobenzoates"},"provenance":null},{"subject":{"scheme":"keyword","value":"Coturnix"},"provenance":null},{"subject":{"scheme":"FOS","value":"04 agricultural and veterinary sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Meloxicam"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Pharmacokinetics of meloxicam, carprofen, and tolfenamic acid after intramuscular and oral administration in Japanese quails (<i>Coturnix coturnix japonica</i>)","subTitle":null,"descriptions":["<jats:title>Abstract</jats:title><jats:p>The aim of this study was to determine the pharmacokinetics of meloxicam (MLX), carprofen (CRP), and tolfenamic acid (TA) in Japanese quails (<jats:italic>Coturnix coturnix japonica</jats:italic>) following intramuscular (IM) and oral administration at doses of 1, 10, and 2 mg/kg, respectively. A total of 72 quails were randomly divided into 3 equal groups as MLX, CRP, and TA. Each group was separated into two sub‐groups that received IM and oral administration of each drug. Plasma concentrations of MLX, CRP, and TA were determined using HPLC‐UV and analyzed by non‐compartmental method. The t<jats:sub>1/2ʎz</jats:sub>and MRT of MLX, CRP, and TA after oral administration were similar to those after IM administration. The V<jats:sub>darea</jats:sub>/F of MLX, CRP, and TA after IM administration was 0.28, 2.05, and 0.20 L/kg. The Cl/F of MLX, CRP, and TA after IM administration was 0.12, 0.19, and 0.09 L/h/kg. MLX, CRP, and TA after oral administration showed significantly lower C<jats:sub>max</jats:sub>and longer T<jats:sub>max</jats:sub>compared with IM administration. The relative bioavailability of MLX, CRP, and TA following oral administration in quails was 76.13%, 61.46%, and 57.32%, respectively. The IM and oral route of MLX, CRP, and TA can be used for the treatment of various conditions in quails. However, further research is necessary to determine the pharmacodynamics and safety of MLX, CRP, and TA before use in quails.</jats:p>"],"publicationDate":"2021-04-12","publisher":"Wiley","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Journal of Veterinary Pharmacology and Therapeutics","issnPrinted":"0140-7783","issnOnline":"1365-2885","issnLinking":null,"ep":"396","iss":null,"sp":"388","vol":"44","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::c91540fc88affde2facebaddeab4db8d","originalIds":["10.1111/jvp.12972","50|doiboost____|c91540fc88affde2facebaddeab4db8d","33846990","3155668942"],"pids":[{"scheme":"doi","value":"10.1111/jvp.12972"},{"scheme":"pmid","value":"33846990"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":19,"influence":3.2995247e-9,"popularity":1.6534175e-8,"impulse":14,"citationClass":"C4","influenceClass":"C5","impulseClass":"C4","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1111/jvp.12972"}],"license":"Wiley Online Library User Agreement","type":"Article","urls":["https://doi.org/10.1111/jvp.12972"],"publicationDate":"2021-04-12","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"33846990"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1111/jvp.12972"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/33846990"],"publicationDate":"2021-11-24","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1111/jvp.12972"},{"scheme":"mag_id","value":"3155668942"}],"type":"Article","urls":["https://dx.doi.org/10.1111/jvp.12972"],"refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar